SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Culper Researchs short report is driving discussion, alleging Cerebras wafers have a much shorter useful life than disclosed and raising concerns about power use and the companys accounting. Traders are split between viewing the claims as credible and dismissing them as unverified, self-interested short-seller allegations; share-unlock supply is also cited as a source of selling pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to a new all-time low is driving discussion, with traders pointing to the companys weak fundamentals and dependence on Trumps profile, while some speculate that midterm results could add pressure. Bearish posts dominate, though a minority expect a rebound tied to a buyback or another deal.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reached its 80th event, triggering final analysis and putting preliminary GPS results expected this quarter in focus. Shares sold off sharply despite the milestone: some traders see the extended trial as encouraging, while others stress that the event itself does not reveal whether GPS worked and that the readout remains a high-risk catalyst.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

A Trian-led consortiums proposed take-private offer has driven attention to Wendys, with traders debating whether the bid undervalues the company and expecting a possible board rejection, counteroffer, or competing bid. Some also speculate that elevated short interest could amplify the reaction, but no deal is confirmed.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Traders are focused on a proposed temporary policy that could allow compounding pharmacies to sell certain previously restricted peptides, a potential new product opportunity for Hims if access is permitted. Bulls see meaningful upside, while skeptics note that approval remains uncertain and the shares have repeatedly stalled or faded despite the news.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase shares plunged after third-quarter results missed expectations and a cautious fourth-quarter outlook underscored weak residential solar demand amid high interest rates and the loss of a federal tax credit. Traders are split between viewing the selloff as an oversold buying opportunity and expecting further pressure; some point to the AI data-center transformer opportunity, while noting it remains a longer-term prospect.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

Attention centers on ServiceNows quarterly earnings and guidance, especially subscription and cRPO growth and whether AI products can translate into recurring revenue. Bulls point to enterprise AI adoption and the companys core business, while skeptics cite high expectations, past post-earnings declines, and recent share-price volatility.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynixs record third-quarter results, shareholder-return plans and outlook for tight AI-memory supply have driven the rally in the shares and lifted sentiment across memory stocks. Many traders see the demand and supply outlook as a durable growth story, while others warn the memory cycle may turn and question whether the strong results are already priced in.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientifics lowered outlook, including an expected fourth-quarter sales decline, is driving the selloff; the company has cited disruption from a cybersecurity incident. Traders are split between calling the drop an overreaction and buying the dip, and criticizing management while warning that weaker growth may persist.

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Genmab - ADR

Genmabs Phase 3 head-and-neck cancer trial of petosemtamab plus Keytruda met both primary endpoints and showed a substantial survival benefit versus Keytruda alone, driving a sharp rally and fresh highs. Traders are broadly upbeat on the clinical data, while some caution that the move may reflect pipeline euphoria and raise valuation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
